doctors to plan more effective therapy.
PURPOSE: This diagnostic trial is studying genetic differences in patients with treated and
untreated acute myeloid leukemia, acute lymphoblastic leukemia, myelodysplastic syndromes,
or multiple myeloma.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
- Cancer Help Line: (800) 639-6918
- Email: email@example.com
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.